Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Status: Enrolling
Updated:  12/31/1969
Tom Baker Cancer Centre - Calgary
mi
from
Calgary,
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Status: Enrolling
Updated: 12/31/1969
Tom Baker Cancer Centre - Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
mi
from
Baltimore, MD
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer
Research Participation: Decision Making and Outcomes in Cancer Clinical Trials
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer
Research Participation: Decision Making and Outcomes in Cancer Clinical Trials
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Shared Decision-Making for Colorectal Cancer Screening
Shared Decision-Making for Colorectal Cancer Screening
Status: Enrolling
Updated:  11/9/2005
Boston Med Center
mi
from
Boston, MA
Shared Decision-Making for Colorectal Cancer Screening
Shared Decision-Making for Colorectal Cancer Screening
Status: Enrolling
Updated: 11/9/2005
Boston Med Center
mi
from
Boston, MA
Click here to add this to my saved trials
Shared Decision-Making for Colorectal Cancer Screening
Shared Decision-Making for Colorectal Cancer Screening
Status: Enrolling
Updated:  11/9/2005
South Boston Community Health Center
mi
from
Boston, MA
Shared Decision-Making for Colorectal Cancer Screening
Shared Decision-Making for Colorectal Cancer Screening
Status: Enrolling
Updated: 11/9/2005
South Boston Community Health Center
mi
from
Boston, MA
Click here to add this to my saved trials
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated:  2/6/2006
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated: 2/6/2006
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy
A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy
Status: Enrolling
Updated:  9/20/2007
Veteran Affairs Medical Center San Diego
mi
from
San Diego, CA
A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy
A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy
Status: Enrolling
Updated: 9/20/2007
Veteran Affairs Medical Center San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial
Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial
Status: Enrolling
Updated:  9/20/2007
Veteran Affairs Medical Center San Diego
mi
from
San Diego, CA
Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial
Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial
Status: Enrolling
Updated: 9/20/2007
Veteran Affairs Medical Center San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Yield and Safety of Colonoscopy in Patients Older Than 80 Years
The Yield and Safety of Screening and Surveillance Colonoscopy in Elderly Patients (> 80 Years)
Status: Enrolling
Updated:  2/3/2009
Kansascity VA Medical center
mi
from
Kansas city, MO
Yield and Safety of Colonoscopy in Patients Older Than 80 Years
The Yield and Safety of Screening and Surveillance Colonoscopy in Elderly Patients (> 80 Years)
Status: Enrolling
Updated: 2/3/2009
Kansascity VA Medical center
mi
from
Kansas city, MO
Click here to add this to my saved trials
Exploratory Study Of The ERCC-1 Gene
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer
Status: Enrolling
Updated:  2/17/2009
Montefiore Medical Center - Weiler Campus
mi
from
Bronx, NY
Exploratory Study Of The ERCC-1 Gene
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer
Status: Enrolling
Updated: 2/17/2009
Montefiore Medical Center - Weiler Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Exploratory Study Of The ERCC-1 Gene
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer
Status: Enrolling
Updated:  2/17/2009
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Exploratory Study Of The ERCC-1 Gene
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer
Status: Enrolling
Updated: 2/17/2009
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Status: Enrolling
Updated:  2/20/2009
VA North Texas Health Care System
mi
from
Dallas, TX
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Status: Enrolling
Updated: 2/20/2009
VA North Texas Health Care System
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Status: Enrolling
Updated:  2/20/2009
Parkland Health and Hospital System
mi
from
Dallas, TX
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Status: Enrolling
Updated: 2/20/2009
Parkland Health and Hospital System
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Status: Enrolling
Updated:  2/20/2009
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Status: Enrolling
Updated: 2/20/2009
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Increasing Primary Care Physician Colorectal Cancer Screening Rates
Increasing Primary Care Physician Colorectal Cancer Screening Rates
Status: Enrolling
Updated:  8/7/2009
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
Increasing Primary Care Physician Colorectal Cancer Screening Rates
Increasing Primary Care Physician Colorectal Cancer Screening Rates
Status: Enrolling
Updated: 8/7/2009
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Impact of a Novel Patient Educational Booklet on Colonoscopy Quality
Impact of a Novel Patient Educational Booklet on Colonoscopy Quality
Status: Enrolling
Updated:  9/10/2009
West Los Angeles VA Healthcare Center
mi
from
Los Angeles, CA
Impact of a Novel Patient Educational Booklet on Colonoscopy Quality
Impact of a Novel Patient Educational Booklet on Colonoscopy Quality
Status: Enrolling
Updated: 9/10/2009
West Los Angeles VA Healthcare Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)
Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)
Status: Enrolling
Updated:  9/17/2009
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)
Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)
Status: Enrolling
Updated: 9/17/2009
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
Improving Colorectal Cancer Screening Rates by Lowering Barriers in Low Income and Non-English Speaking Populations: The Chelsea Colorectal Cancer Screening Project
Status: Enrolling
Updated:  4/30/2010
MGH Chelsea Health Center
mi
from
Chelsea, MA
Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
Improving Colorectal Cancer Screening Rates by Lowering Barriers in Low Income and Non-English Speaking Populations: The Chelsea Colorectal Cancer Screening Project
Status: Enrolling
Updated: 4/30/2010
MGH Chelsea Health Center
mi
from
Chelsea, MA
Click here to add this to my saved trials
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated:  5/3/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated: 5/3/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated:  5/3/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated: 5/3/2010
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated:  5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Status: Enrolling
Updated: 5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery
Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery
Status: Enrolling
Updated:  6/29/2010
VA North Texas Health Care System
mi
from
Dallas, TX
Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery
Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery
Status: Enrolling
Updated: 6/29/2010
VA North Texas Health Care System
mi
from
Dallas, TX
Click here to add this to my saved trials
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Cancer Survivors Online Self-Management Workshop
Status: Enrolling
Updated:  9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Cancer Survivors Online Self-Management Workshop
Status: Enrolling
Updated: 9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated:  9/28/2010
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated: 9/28/2010
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)
Status: Enrolling
Updated:  6/21/2011
Laser Surgery Care
mi
from
New York, NY
Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)
Status: Enrolling
Updated: 6/21/2011
Laser Surgery Care
mi
from
New York, NY
Click here to add this to my saved trials
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
A Phase I Study of NK012 in Combination With Infusional 5-fluorouracil and Leucovorin in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  6/24/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
A Phase I Study of NK012 in Combination With Infusional 5-fluorouracil and Leucovorin in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/24/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Comparison of Study Method Versus Conventional Method for Performing Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Status: Enrolling
Updated:  7/10/2011
Sacramento VA Medical Center
mi
from
Mather, CA
Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Comparison of Study Method Versus Conventional Method for Performing Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Status: Enrolling
Updated: 7/10/2011
Sacramento VA Medical Center
mi
from
Mather, CA
Click here to add this to my saved trials
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated:  9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated: 9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Alabama Digestive Disorders Center
mi
from
Huntsville, AL
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Alabama Digestive Disorders Center
mi
from
Huntsville, AL
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Indiana University Hospital
mi
from
Indianapolis, IN
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Indiana University Hospital
mi
from
Indianapolis, IN
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Louisville Gastroenterology Associates
mi
from
Louisville, KY
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Louisville Gastroenterology Associates
mi
from
Louisville, KY
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Specialists in Gastroenterology
mi
from
St. Louis, MO
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Specialists in Gastroenterology
mi
from
St. Louis, MO
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Research Associates of New York
mi
from
, NY
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Research Associates of New York
mi
from
, NY
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
UNC Chapel Hill Gastroenterology and Hepatology
mi
from
Chapel Hill, NC
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
UNC Chapel Hill Gastroenterology and Hepatology
mi
from
Chapel Hill, NC
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Dayton Gstroenterology Inc.
mi
from
Dayton, OH
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Dayton Gstroenterology Inc.
mi
from
Dayton, OH
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Franklin Gastroenterology
mi
from
Franklin, TN
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Franklin Gastroenterology
mi
from
Franklin, TN
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Gastroenterology Consultants
mi
from
Houston, TX
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Gastroenterology Consultants
mi
from
Houston, TX
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Pasadena Gastroenterology Associates, P.A.
mi
from
Pasadena, TX
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Pasadena Gastroenterology Associates, P.A.
mi
from
Pasadena, TX
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated:  12/1/2011
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Status: Archived
Updated: 12/1/2011
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Erlotinib in Treating Patients With a History of Stage I, Stage II, or Stage III Colorectal Cancer or Adenoma
A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon
Status: Enrolling
Updated:  3/13/2012
Veterans Affairs Medical Center - Long Beach
mi
from
Long Beach, CA
Erlotinib in Treating Patients With a History of Stage I, Stage II, or Stage III Colorectal Cancer or Adenoma
A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon
Status: Enrolling
Updated: 3/13/2012
Veterans Affairs Medical Center - Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
Erlotinib in Treating Patients With a History of Stage I, Stage II, or Stage III Colorectal Cancer or Adenoma
A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon
Status: Enrolling
Updated:  3/13/2012
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
mi
from
Orange, CA
Erlotinib in Treating Patients With a History of Stage I, Stage II, or Stage III Colorectal Cancer or Adenoma
A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon
Status: Enrolling
Updated: 3/13/2012
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Erlotinib in Treating Patients With a History of Stage I, Stage II, or Stage III Colorectal Cancer or Adenoma
A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon
Status: Enrolling
Updated:  3/13/2012
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Erlotinib in Treating Patients With a History of Stage I, Stage II, or Stage III Colorectal Cancer or Adenoma
A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon
Status: Enrolling
Updated: 3/13/2012
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated:  3/26/2012
Access Community Health Network
mi
from
Chicago, IL
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated: 3/26/2012
Access Community Health Network
mi
from
Chicago, IL
Click here to add this to my saved trials
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated:  3/26/2012
University of Illinois Hospital & Health Sciences System
mi
from
Chicago, IL
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated: 3/26/2012
University of Illinois Hospital & Health Sciences System
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
Status: Enrolling
Updated:  4/5/2012
IU Health
mi
from
Indianapolis, IN
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
Status: Enrolling
Updated: 4/5/2012
IU Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Status: Enrolling
Updated:  4/6/2012
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Status: Enrolling
Updated: 4/6/2012
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Status: Enrolling
Updated:  4/18/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Status: Enrolling
Updated: 4/18/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract
A Pilot Study of Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract
Status: Enrolling
Updated:  4/25/2012
Massachusetts General Hospital
mi
from
Boston, MA
Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract
A Pilot Study of Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract
Status: Enrolling
Updated: 4/25/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials